CL2018002094A1 - Un proceso para preparar compuesto de pirrolo[3,2–d]pirimidina y su intermediario - Google Patents
Un proceso para preparar compuesto de pirrolo[3,2–d]pirimidina y su intermediarioInfo
- Publication number
- CL2018002094A1 CL2018002094A1 CL2018002094A CL2018002094A CL2018002094A1 CL 2018002094 A1 CL2018002094 A1 CL 2018002094A1 CL 2018002094 A CL2018002094 A CL 2018002094A CL 2018002094 A CL2018002094 A CL 2018002094A CL 2018002094 A1 CL2018002094 A1 CL 2018002094A1
- Authority
- CL
- Chile
- Prior art keywords
- pyrimidine
- compound
- preparing
- preparing pyrrolo
- pyrrolo compound
- Prior art date
Links
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- -1 PIRROLO COMPOUND Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610082028.3A CN107043378A (zh) | 2016-02-05 | 2016-02-05 | 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2018002094A1 true CL2018002094A1 (es) | 2018-12-07 |
Family
ID=59500148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018002094A CL2018002094A1 (es) | 2016-02-05 | 2018-08-03 | Un proceso para preparar compuesto de pirrolo[3,2–d]pirimidina y su intermediario |
Country Status (28)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11999750B2 (en) | 2022-01-12 | 2024-06-04 | Denali Therapeutics Inc. | Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide |
| US12358928B2 (en) | 2016-02-05 | 2025-07-15 | Denali Therapeutics Inc. | Compounds, compositions and methods |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107043380A (zh) * | 2016-02-05 | 2017-08-15 | 正大天晴药业集团股份有限公司 | 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途 |
| WO2020162705A1 (ko) | 2019-02-08 | 2020-08-13 | 성균관대학교산학협력단 | 톨-유사 수용체 7 또는 8 작용자와 콜레스테롤의 결합체 및 그 용도 |
| US20230100429A1 (en) | 2020-03-02 | 2023-03-30 | Progeneer Inc. | Live-pathogen-mimetic nanoparticles based on pathogen cell wall skeleton, and production method thereof |
| JP7690222B2 (ja) | 2020-08-04 | 2025-06-10 | プロジェニア インコーポレイテッド | 動力学的制御が可能なアジュバントを含むｍＲＮＡワクチン |
| JP2023536954A (ja) | 2020-08-04 | 2023-08-30 | プロジェニア インコーポレイテッド | 活性化部位が一時的に不活性化したトール様受容体７または８作用薬と機能性薬物の結合体およびその用途 |
| WO2022031011A1 (ko) | 2020-08-04 | 2022-02-10 | 성균관대학교산학협력단 | 동력학적으로 작용하는 아주번트 앙상블 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009082247A1 (en) * | 2007-12-21 | 2009-07-02 | Industrial Research Limited | Process for preparing immucillins having a methylene link |
| EA021377B9 (ru) | 2008-12-09 | 2015-09-30 | Джилид Сайэнс, Инк. | Модуляторы толл-подобных рецепторов |
| EP2906563B1 (en) * | 2012-10-10 | 2018-02-28 | Janssen Sciences Ireland UC | Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases |
| AU2013348217B2 (en) * | 2012-11-20 | 2016-10-06 | Glaxosmithkline Llc | Novel compounds |
| SG11201503282RA (en) * | 2012-11-20 | 2015-06-29 | Glaxosmithkline Llc | Novel compounds |
| MX362341B (es) * | 2014-05-01 | 2019-01-11 | Novartis Ag | Compuestos y composiciones como agonistas del receptor tipo toll 7. |
| MX386981B (es) | 2014-08-15 | 2025-03-19 | Chia Tai Tianqing Pharmaceutical Group Co Ltd | Compuestos de pirrolopirimidina usados como agonistas del receptor de tipo toll 7 (tlr7). |
| CN105367576A (zh) | 2014-08-15 | 2016-03-02 | 正大天晴药业集团股份有限公司 | 作为tlr7激动剂的吡咯并嘧啶化合物 |
| ES2833927T3 (es) | 2015-11-05 | 2021-06-16 | Chai Tai Tianqing Pharmaceutical Group Co Ltd | Compuesto de 7-(tiazol-5-il)pirrolopirimidina como agonista de TLR7 |
| CN107043379A (zh) * | 2016-02-05 | 2017-08-15 | 正大天晴药业集团股份有限公司 | 一种tlr7激动剂的晶型a、其制备方法和医药用途 |
| CN107043377A (zh) * | 2016-02-05 | 2017-08-15 | 正大天晴药业集团股份有限公司 | 一种tlr7激动剂的三氟乙酸盐、晶型b及其制备方法、药物组合物和用途 |
| CN107043380A (zh) * | 2016-02-05 | 2017-08-15 | 正大天晴药业集团股份有限公司 | 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途 |
-
2016
- 2016-02-05 CN CN201610082028.3A patent/CN107043378A/zh active Pending
-
2017
- 2017-02-03 TW TW106103696A patent/TW201728590A/zh unknown
- 2017-02-04 CN CN201780009748.XA patent/CN108602832B/zh active Active
- 2017-02-04 UA UAA201809087A patent/UA124100C2/uk unknown
- 2017-02-04 KR KR1020187024628A patent/KR102371500B1/ko active Active
- 2017-02-04 EA EA201891769A patent/EA034581B1/ru not_active IP Right Cessation
- 2017-02-04 CA CA3013520A patent/CA3013520C/en active Active
- 2017-02-04 HR HRP20210103TT patent/HRP20210103T1/hr unknown
- 2017-02-04 AU AU2017214134A patent/AU2017214134B2/en active Active
- 2017-02-04 EP EP17747006.9A patent/EP3412673B1/en active Active
- 2017-02-04 ES ES17747006T patent/ES2852323T3/es active Active
- 2017-02-04 NZ NZ744885A patent/NZ744885A/en unknown
- 2017-02-04 MY MYPI2018702701A patent/MY190551A/en unknown
- 2017-02-04 SG SG11201806685VA patent/SG11201806685VA/en unknown
- 2017-02-04 SI SI201730605T patent/SI3412673T1/sl unknown
- 2017-02-04 MX MX2018009502A patent/MX374298B/es active IP Right Grant
- 2017-02-04 WO PCT/CN2017/072893 patent/WO2017133686A1/zh not_active Ceased
- 2017-02-04 US US16/075,300 patent/US10654856B2/en active Active
- 2017-02-04 BR BR112018015879-8A patent/BR112018015879B1/pt active IP Right Grant
- 2017-02-04 DK DK17747006.9T patent/DK3412673T3/da active
- 2017-02-04 HU HUE17747006A patent/HUE053455T2/hu unknown
- 2017-02-04 PL PL17747006T patent/PL3412673T3/pl unknown
- 2017-02-04 JP JP2018540720A patent/JP6877449B2/ja active Active
- 2017-02-04 LT LTEP17747006.9T patent/LT3412673T/lt unknown
- 2017-02-04 PT PT177470069T patent/PT3412673T/pt unknown
- 2017-02-06 AR ARP170100298A patent/AR107549A1/es active IP Right Grant
-
2018
- 2018-08-02 PH PH12018501642A patent/PH12018501642A1/en unknown
- 2018-08-03 CL CL2018002094A patent/CL2018002094A1/es unknown
- 2018-08-05 IL IL260999A patent/IL260999B/en active IP Right Grant
-
2020
- 2020-04-13 US US16/847,394 patent/US20200239484A1/en not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12358928B2 (en) | 2016-02-05 | 2025-07-15 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| US11999750B2 (en) | 2022-01-12 | 2024-06-04 | Denali Therapeutics Inc. | Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018002094A1 (es) | Un proceso para preparar compuesto de pirrolo[3,2–d]pirimidina y su intermediario | |
| AR132627A2 (es) | Procesos para preparar compuestos intermediarios de utilidad para sintetizar compuestos de carbamoilpiridona policíclicos | |
| NZ726356A (en) | Processes for preparing antiviral compounds | |
| MX2015017993A (es) | Pigmentos de brillo metalico. | |
| MX380239B (es) | Derivados de 4h-pirrol[3,2-c]piridin-4-ona. | |
| AU2014270524A8 (en) | 2-phenylimidazo [1,2-a]pyrimidines as imaging agents | |
| NZ722624A (en) | Fused pyrimidines as inhibitors of p97 complex | |
| UY36737A (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
| CL2018002101A1 (es) | Un trifluoroacetato de agonista de tlr7, la forma cristalina b, proceso de preparación y su utilización | |
| WO2018029711A3 (en) | Process for the preparation of venetoclax | |
| NZ711192A (en) | Process for making benzoxazepin compounds | |
| UY36746A (es) | Método para la síntesis de derivados de rapamicina | |
| EP3096762C0 (en) | PYRAZOLO[1,5-A]PYRIMIDINES AS ANTIVIRAL COMPOUNDS | |
| PH12017500839A1 (en) | Triazolo[4,5-d]pyrimidines as agonists of the cannabinoid receptor 2 | |
| BR112018006005A2 (pt) | composto bicíclico e uso do mesmo para inibição de suv39h2 | |
| CL2018002344A1 (es) | Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina | |
| BR112016022437A2 (pt) | Processo para preparação de (2s,5r)-6-(benziloxi)-7-oxo-1,6- diazabiciclo[3,2,1]octano-2-carboxilato de sódio | |
| MX382659B (es) | Proceso para la preparación de derivados de tiazol. | |
| CU20190035A7 (es) | Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina | |
| AR101951A1 (es) | Síntesis de ent-progesterona e intermediarios de la misma | |
| MX2015011881A (es) | Proceso para la preparacion de 3,7-dimetilnonan-1-ol. | |
| MX2019000984A (es) | Proceso para preparacion de indanonas. | |
| TN2017000065A1 (en) | A tetrahydropyrrolo[3,4-d][1,3]thiazine-derivative as bace inhibitor | |
| MX2021006739A (es) | Formas cristalinas de 4-ciano-n-(2-(4,4-dimetilciclohex-1-en-1-il) -6-(2,2,6,6-tetrametiltetrahidro-2h-piran-4-il)piridin-3-il)-1h-i midazol-2-carboxamida. | |
| CO2018001307A2 (es) | Un proceso mejorado para la preparación de tetrofosmina o su sal de adición de ácido |